• Ashwani Arya Department of Pharmaceutical Education and Research, BPS Women University, South Campus, Bhainswal Kalan, Sonipat ( Haryana)
  • Gulshan Sindhwani




Anxiety disorders are among the most common mental, emotional, and behavioral problems. These affect one-eighth of the total population worldwide.
Anxiety disorders are a group of mental disorders characterized by irritability, fear, insomnia, nervousness, tachycardia, inability to concentrate,
poor coping skills, palpitation, sweating, agoraphobia, and social withdrawal. Brain regions and networks involved in anxiety symptomatology is
an effort to better understand the mechanism involved and to develop more effective treatments for the anxiety disorders. Thus, neuroanatomical
and neuroimaging research in anxiety disorders has centered on the role of the amygdala, reciprocal connections between the amygdala and the
prefrontal cortex, and, most recently, alterations in interoceptive processing by the anterior insula. Anxiety disorders are characterized by alterations
in a diverse range of neurochemical systems, suggesting ample novel targets for drug therapies. The neurotransmitter like corticotropin-releasing
factor, neuropeptides (substance P, neuropeptide Y, oxytocin, orexin, and galanin) are implicated in anxiety pathways. Each of these active areas of
research holds promise for expanding and improving evidence-based treatment options for individuals suffering with clinical anxiety. Therefore,
this article gives the information on the neurocognitive mechanisms, causes, neurotransmitter involved in anxiety disorders and emphasize on the
therapeutic targets for anxiety disorders.
Keywords: Anxiety, Stress, Amygdala, Corticotropin releasing factor, Insula, Thalamus.


Olatunji BO, Cisler JM, Tolin DF. Quality of life in the anxiety disorders: A meta-analytic review. Clin Psychol Rev 2007;27(5):572-81.

Shin LM, Liberzon I. The neurocircuitry of fear, stress, and anxiety disorders. Neuropsychopharmacology 2010;35(1):169-91.

Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005;62(6):617-27.

Ninan PT. Dissolving the burden of generalized anxiety disorder. J Clin Psychiatry 2001;62(19):5-10.

Damsa C, Kosel M, Moussally J. Current status of brain imaging in anxiety disorders. Curr Opin Psychiatry 2009;22(1):96-110.

LeDoux JE. The amygdala and emotion: A view through fear. In: Aggleton JP, editor. The Amygdala: A Function Analysis. 2nd ed. New York: Oxford University Press; 2000. p. 289-310.

Kent JM, Mathew SJ, Gorman JM. Molecular targets in the treatment of anxiety. Biol Psychiatry 2002;52(10):1008-30.

American Psychiatric Association. Anxiety disorders. In: Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 2000. p. 429-84.

Neumeister A, Daher RJ, Charney DS. Anxiety disorders: Noradrenergic neurotransmission. Handb Exp Pharmacol 2005;169:205-23.

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Text Revision. Washington, DC: American Psychiatric Association; 2000. p. 29-430.

Shelton CI. Diagnosis and management of anxiety disorders. J Am Osteopath Assoc 2004;104(3):2-5.

Burrows GD, Vine R. Anxiety disorders. In: Bloch S, Singh BS, editors. Foundations of Clinical Psychiatry. Melbourne: Melbourne University Press; 1994. p. 112-27.

NIMH, National Institute of Mental Health. Anxiety Disorders. Bethesda, MD: U.S. Department of Health and Human Services - National Institutes of Health, (NIH). Publication No. 09 3879. 2009. p. 1-24.

Hettema JM, Annas P, Neale MC, Kendler KS, Fredrikson M. A twin study of the genetics of fear conditioning. Arch Gen Psychiatry 2003;60(7):702-8.

Vendruscolo LF, Terenina-Rigaldie E, Raba F, Ramos A, Takahashi RN, Mormede P. Evidence for a female-specific effect of a chromosome 4 locus on anxiety-related behaviors and ethanol drinking in rats. Genes Brain Behav 2006;6:441-50.

Stein DJ, Newman TK, Savitz J, Ramesar R. Warriors versus worriers: The role of COMT gene variants. CNS Spectr 2006;11(10):745-8.

Chochinov HM, Kristjanson LJ, Hack TF, Hassard T, McClement S, Harlos M. Personality, neuroticism, and coping towards the end of life. J Pain Symptom Manage 2006;32(4):332-41.

Gladstone GL, Parker GB, Malhi GS. Do bullied children become anxious and depressed adults? A cross-sectional investigation of the correlates of bullying and anxious depression. J Nerv Ment Dis 2006;194(3):201-8.

Drevets WC. Neuroimaging studies of mood disorders. Biol Psychiatry 2000;48(8):813-29.

Szyf M, Weaver IC, Champagne FA, Diorio J, Meaney MJ. Maternal programming of steroid receptor expression and phenotype through DNA methylation in the rat. Front Neuroendocrinol 2005;26(3-4):139-62.

Grillon C. Startle reactivity and anxiety disorders: Aversive conditioning, context, and neurobiology. Biol Psychiatry 2002;52:958-75.

Millan MJ. The neurobiology and control of anxious states. Prog Neurobiol 2003;70(2):83-244.

Walker DL, Toufexis DJ, Davis M. Role of the bed nucleus of the stria terminalis versus the amygdala in fear, stress, and anxiety. Eur J Pharmacol 2003;463(1-3):199-216.

Bonne O, Grillon C, Vythilingam M, Neumeister A, Charney DS. Adaptive and maladaptive psychobiological responses to severe psychological stress: Implications for the discovery of novel pharmacotherapy. Neurosci Biobehav Rev 2004;28(1):65-94.

Davis M, Whalen PJ. The amygdala: Vigilance and emotion. Mol Psychiatry 2001;6:13-34.

Bush G, Luu P, Posner MI. Cognitive and emotional influences in anterior cingulate cortex. Trends Cogn Sci 2000;4(6):215-22.

Sotres-Bayon F, Cain CK, LeDoux JE. Brain mechanisms of fear extinction: Historical perspectives on the contribution of prefrontal cortex. Biol Psychiatry 2006;60(4):329-36.

Zald DH, Kim SW. Anatomy and function of the orbital frontal cortex, II: Function and relevance to obsessive-compulsive disorder. J Neuropsychiatry Clin Neurosci 1996;8(3):249-61.

Bechara A, Damasio AR, Damasio H, Anderson SW. Insensitivity to future consequences following damage to human prefrontal cortex. Cognition 1994;50(1-3):7-15.

Graybiel AM. The basal ganglia: Learning new tricks and loving it. Curr Opin Neurobiol 2005;15(6):638-44.

Mittleman G, Whishaw IQ, Jones GH, Koch M, Robbins TW. Cortical, hippocampal, and striatal mediation of schedule-induced behaviors. Behav Neurosci 1990;104:399-409.

Packard MG, White NM. Lesions of the caudate nucleus selectively impair reference memory†acquisition in the radial maze. Behav Neural Biol 1990;53:39-50.

Pinault D. The thalamic reticular nucleus: Structure, function and concept. Brain Res Brain Res Rev 2004;46(1):1-31.

Craig AD. How do you feel – Now? The anterior insula and human awareness. Nat Rev Neurosci 2009;10(1):59-70.

Shah SG, Klumpp H, Angstadt M, Nathan PJ, Phan KL. Amygdala and insula response to emotional images in patients with generalized social anxiety disorder. J Psychiatry Neurosci 2009;34(4):296-302.

Grillon C, Morgan CA. Fear-potentiated startle conditioning to explicit and contextual cues in Gulf War veterans with posttraumatic stress disorder. Biol Psychiatry 1998;44:990-7.

Sapolsky RM, Plotsky PM. Hypercortisolism and its possible neural bases. Biol Psychiatry 1990;27(9):937-52.

Choi DW, Farb DH, Fischbach GD. Chlordiazepoxide selectively potentiates GABA conductance of spinal cord and sensory neurons in cell culture. J Neurophysiol 1981;45(4):621-31.

Barnett SD, Kramer ML, Casat CD, Connor KM, Davidson JR. Efficacy of olanzapine in social anxiety disorder: A pilot study. J Psychopharmacol 2002;16(4):365-8.

Harro J, Vasar E, Bradwejn J. CCK in animal and human research on anxiety. Trends Pharmacol Sci 1993;14(6):244-9.

Phan KL, Wager T, Taylor SF, Liberzon I. Functional neuroanatomy of emotion: A meta-analysis of emotion activation studies in PET and fMRI. Neuroimage 2002;16(2):331-48.

Phelps EA, Delgado MR, Nearing KI, LeDoux JE. Extinction learning in humans: Role of the amygdala and vmPFC. Neuron 2004;43(6):897-905.

Kober H, Barrett LF, Joseph J, Bliss-Moreau E, Lindquist K, Wager TD. Functional grouping and cortical-subcortical interactions in emotion: A meta-analysis of neuroimaging studies. Neuroimage 2008;42(2):998-1031.

Paulus MP. The role of neuroimaging for the diagnosis and treatment of anxiety disorders. Depress Anxiety 2008;25(4):348-56.

Freese JL, Amaral DG. Neuroanatomy of the primate amygdala. In: Whalen PJ, Phelps EA, editors. The Human Amygdala. New York: Guilford Press; 2009. p. 3-42.

Engel K, Bandelow B, Gruber O, Wedekind D. Neuroimaging in anxiety disorders. J Neural Transm (Vienna) 2009;116:703-16.

Davis M. The role of the amygdala in fear and anxiety. Annu Rev Neurosci 1992;15:353-75.

Rauch SL, Savage CR, Alpert NM, Fischman AJ, Jenike MA. The functional neuroanatomy of anxiety: A study of three disorders using positron emission tomography and symptom provocation. Biol Psychiatry 1997;42(6):446-52.

McDonald AJ. Cortical pathways to the mammalian amygdala. Prog Neurobiol 1998;55(3):257-332.

Canteras NS, Swanson LW. Projections of the ventral subiculum to the amygdala, septum, and hypothalamus: A PHAL anterograde tract-tracing study in the rat. J Comp Neurol 1992;324:180-94.

Schwaber JS, Kapp BS, Higgins GA, Rapp PR. Amygdaloid and basal forebrain direct connections with the nucleus of the solitary tract and the dorsal motor nucleus. J Neurosci 1982;2(10):1424-38.

Holsboer F. Corticotropin-releasing hormone modulators and depression. Curr Opin Investig Drugs 2003;4:46-50.

Abercrombie HC, Kalin NH, Thurow ME, Rosenkranz MA, Davidson RJ. Cortisol variation in humans affects memory for emotionally laden and neutral information. Behav Neurosci 2003;117(1):505-16.

Cahill L, Alkire MT. Epinephrine enhancement of human memory consolidation: Interaction with arousal at encoding. Neurobiol Learn Mem 2003;79(3):194-8.

Bergink V, van Megen HJ, Westenberg HG. Glutamate and anxiety. Eur Neuropsychopharmacol 2004;14(2):175-83.

Mathew SJ. Exploring glutamate function in mood and anxiety disorders; rationale and future directions. CNS Spectr 2005;10:806-7.

Swanson CJ, Bures M, Johnson MP, Linden AM, Monn JA, Schoepp DD. Metabotropic glutamate receptors as novel targets for anxiety and stress disorders. Nat Rev Drug Discov 2005;4:131-44.

Ebner K, Singewald N. The role of substance P in stress and anxiety responses. Amino Acids 2006;31(3):251-72.

Santarelli L, Gobbi G, Blier P, Hen R. Behavioral and physiologic effects of genetic or pharmacologic inactivation of the substance P receptor (NK1). J Clin Psychiatry 2002;63(11):11-7.

Huber D, Veinante P, Stoop R. Vasopressin and oxytocin excite distinct neuronal populations in the central amygdala. Science 2005;308:245-8.

Barrera G, Echevarria DJ, Poulin JF, Laforest S, Drolet G, Morilak DA. One for all or one for one: Does co-transmission unify the concept of a brain galanin system†or clarify any consistent role in anxiety? Neuropeptides 2005;39(3):289-92.

Branchek TA, Smith KE, Gerald C, Walker MW. Galanin receptor subtypes. Trends Pharmacol Sci 2000;21(3):109-17.

Rajarao SJ, Platt B, Sukoff SJ, Lin Q, Bender CN, Nieuwenhuijsen BW, et al. Anxiolytic-like activity of the non-selective galanin receptor agonist, galnon. Neuropeptides 2007;41(5):307-20.



How to Cite

Arya, A., and G. Sindhwani. “A REVIEW ON THE NEURAL CIRCUITS IN ANXIETY DISORDERS”. Asian Journal of Pharmaceutical and Clinical Research, vol. 9, no. 9, Dec. 2016, pp. 26-31, doi:10.22159/ajpcr.2016.v9s3.11820.



Review Article(s)